BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 33396569)

  • 1. Changes in Gene and Protein Expression of Metalloproteinase-2 and -9 and Their Inhibitors TIMP2 and TIMP3 in Different Parts of Fluoride-Exposed Rat Brain.
    Łukomska A; Baranowska-Bosiacka I; Dec K; Pilutin A; Tarnowski M; Jakubczyk K; Żwierełło W; Skórka-Majewicz M; Chlubek D; Gutowska I
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinases MMP1, MMP2, MMP9 and their tissue inhibitors TIMP1, TIMP2, TIMP3 in head and neck cancer: an immunohistochemical study.
    Pietruszewska W; Bojanowska-Poźniak K; Kobos J
    Otolaryngol Pol; 2016 Jun; 70(3):32-43. PubMed ID: 27386931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated ratio of MMP2/MMP9 activity is associated with poor response to chemotherapy in osteosarcoma.
    Kunz P; Sähr H; Lehner B; Fischer C; Seebach E; Fellenberg J
    BMC Cancer; 2016 Mar; 16():223. PubMed ID: 26979530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TIMP1, TIMP2, and TIMP4 are increased in aqueous humor from primary open angle glaucoma patients.
    Ashworth Briggs EL; Toh T; Eri R; Hewitt AW; Cook AL
    Mol Vis; 2015; 21():1162-72. PubMed ID: 26539028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes of matrix metalloproteinase 2,9 and tissue inhibitor of metalloproteinase 1, 2, 3 expression level in aged rat lung].
    Zhao ZJ; Liu XM; Zhou GP
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Feb; 40(1):101-4. PubMed ID: 18278151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor binding protein related protein 1 knockdown attenuates hepatic fibrosis via the regulation of MMPs/TIMPs in mice.
    Ren JJ; Huang TJ; Zhang QQ; Zhang HY; Guo XH; Fan HQ; Li RK; Liu LX
    Hepatobiliary Pancreat Dis Int; 2019 Feb; 18(1):38-47. PubMed ID: 30243878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TIMP2 and TIMP3 have divergent roles in early renal tubulointerstitial injury.
    Wang Z; Famulski K; Lee J; Das SK; Wang X; Halloran P; Oudit GY; Kassiri Z
    Kidney Int; 2014 Jan; 85(1):82-93. PubMed ID: 23760282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tamoxifen-induced alterations in the expression of selected matrix metalloproteinases (MMP-2, -9, -10, and -13) and their tissue inhibitors (TIMP-2 and -3) in the chicken ovary.
    Wolak D; Hrabia A
    Theriogenology; 2020 May; 148():208-215. PubMed ID: 31753476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMP3, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma.
    Bhuvarahamurthy V; Kristiansen GO; Johannsen M; Loening SA; Schnorr D; Jung K; Staack A
    Oncol Rep; 2006 May; 15(5):1379-84. PubMed ID: 16596214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rat pancreatic stellate cells secrete matrix metalloproteinases: implications for extracellular matrix turnover.
    Phillips PA; McCarroll JA; Park S; Wu MJ; Pirola R; Korsten M; Wilson JS; Apte MV
    Gut; 2003 Feb; 52(2):275-82. PubMed ID: 12524413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human optic nerve head astrocytes.
    Agapova OA; Ricard CS; Salvador-Silva M; Hernandez MR
    Glia; 2001 Mar; 33(3):205-16. PubMed ID: 11241738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strong association of tissue inhibitor of metalloproteinase (TIMP)-2 and -3 promoter single nucleotide polymorphisms with risk of colorectal cancer in ethnic Kashmiri population - a case control study.
    Banday MZ; Sameer AS
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988064
    [No Abstract]   [Full Text] [Related]  

  • 13. Downregulation of reversion-inducing cysteine-rich protein with Kazal motifs in malignant melanoma: inverse correlation with membrane-type 1-matrix metalloproteinase and tissue inhibitor of metalloproteinase 2.
    Jacomasso T; Trombetta-Lima M; Sogayar MC; Winnischofer SM
    Melanoma Res; 2014 Feb; 24(1):32-9. PubMed ID: 24335752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Angiogenic Effect of microRNA-21 Targeting TIMP3 through the Regulation of MMP2 and MMP9.
    Hu J; Ni S; Cao Y; Zhang T; Wu T; Yin X; Lang Y; Lu H
    PLoS One; 2016; 11(2):e0149537. PubMed ID: 26872030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatiotemporal expression patterns of metalloproteinases and their inhibitors in the postnatal developing rat cerebellum.
    Vaillant C; Didier-Bazès M; Hutter A; Belin MF; Thomasset N
    J Neurosci; 1999 Jun; 19(12):4994-5004. PubMed ID: 10366632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of MMP2, MMP9, MT1-MMP, TIMP1, and TIMP2 mRNA in valvular lesions of the heart.
    Soini Y; Satta J; Määttä M; Autio-Harmainen H
    J Pathol; 2001 Jun; 194(2):225-31. PubMed ID: 11400152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of gelatinases (MMP-2 and MMP-9) and tissue inhibitors of metalloproteinases (TIMP-2 and TIMP-3) in the chicken ovary in relation to follicle development and atresia.
    Hrabia A; Wolak D; Kwaśniewska M; Kieronska A; Socha JK; Sechman A
    Theriogenology; 2019 Feb; 125():268-276. PubMed ID: 30481606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of tissue inhibitor of metalloproteinases 2 leads to exacerbated left ventricular dysfunction and adverse extracellular matrix remodeling in response to biomechanical stress.
    Kandalam V; Basu R; Moore L; Fan D; Wang X; Jaworski DM; Oudit GY; Kassiri Z
    Circulation; 2011 Nov; 124(19):2094-105. PubMed ID: 21986284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis.
    Milner JM; Rowan AD; Cawston TE; Young DA
    Arthritis Res Ther; 2006; 8(5):R142. PubMed ID: 16919164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TIMP3 is the primary TIMP to regulate agonist-induced vascular remodelling and hypertension.
    Basu R; Lee J; Morton JS; Takawale A; Fan D; Kandalam V; Wang X; Davidge ST; Kassiri Z
    Cardiovasc Res; 2013 Jun; 98(3):360-71. PubMed ID: 23524300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.